Why the disclaimer is legitimate
A prior authorization decides one question: whether, on the clinical information submitted before the service, the payer considers the service medically necessary and covered.
It cannot decide the other questions, because they are not answerable yet. Whether the patient is still eligible on the date of service. Whether the plan's benefit design covers this service for this member this year. Whether the final operative note and diagnosis codes match what was described in advance. Whether the claim is coded correctly, submitted on time, and free of the ordinary defects that cause any claim to fail. Whether another payer is primary.
None of that is knowable at the moment of approval, and a payer that guaranteed payment in advance would be guaranteeing outcomes it cannot see. Experienced revenue-cycle leaders make this point firmly and they are right to. An approval is a determination about medical necessity based on pre-service evidence, and the medical record for the episode still has to support what was authorized.
Concede all of that, and the real problem is still standing.
The problem is not the disclaimer. It is that the loop never closes.
Follow one authorized case to its end.
The request is approved. The case is performed. The claim goes out. Weeks later, a remittance arrives — paid in full, paid short, or denied, with a reason code attached. If it denied, the denial has no memory of the authorization. It does not reference the approval, the reviewer, the clinical package that was assembled, or the days the team spent assembling it. It is a separate document about a separate transaction, and it arrives in a separate work queue, often handled by a separate person or a separate company.
Now ask a simple question about the whole population rather than the one case: of the cases approved last quarter, what share were ultimately paid in full?
Almost no provider organization can answer. Not because the data is missing — the authorizations exist and the remittances exist — but because nothing joins them. The authorization record lives with the payer, in a portal, or in a fax log. The remittance lives in the practice management system or with the billing company. The two are never reconciled against each other, so the approved population and the paid population are never compared. This is the same gap worked through, leak by leak, on our revenue-leak playbook.
That is the gap. Not that approval fails to guarantee payment, but that nobody ever finds out which approvals failed, or why.
What that gap actually costs
Three things follow from a loop that never closes, and each of them compounds.
Nothing gets learned.If a particular payer routinely approves a procedure and then reimburses it below the contracted rate, or denies it on a documentation technicality that could have been pre-empted, that pattern is discoverable in about an hour — but only by someone comparing the two populations. Uncompared, the pattern simply repeats, case after case, indefinitely. A denial at least produces a reason code and usually enters a work queue; an underpayment produces a payment, which reads as a success and generally triggers nothing at all — see our denial-management playbook for the denial side of that contrast.
The risk stays with the provider. The organization has already spent the staff time, performed the service, and consumed the supplies before it learns whether the case will be paid. That is a real transfer of financial risk, and it is tolerable only if the failure rate is known. Nobody tolerates an unmeasured risk on purpose; they tolerate it because they have never seen it totalled.
The team's judgment gets discounted. People who work authorizations know which payers and which procedures go wrong. That knowledge stays anecdotal, and anecdote loses to a spreadsheet in every budget conversation. The same knowledge, expressed as a rate, wins.
What closing the loop takes
Less than people expect, and no new clinical system.
It takes joining the authorization record to the remittance for the same case, so that every approved case carries its own eventual outcome. From that join, three numbers become available: the share of approved cases paid in full, the share paid below the contracted rate, and the share denied outright after approval — each broken out by payer, by procedure, and by denial reason.
The first time an organization sees those three numbers, the reaction is usually not surprise at the size. It is recognition. The pattern was already known by the people doing the work. It had simply never been counted, and so had never been actionable.
Of the cases you had approved last quarter, how many were paid in full? If that number does not exist anywhere in your systems, you are in ordinary company — the authorization and the remittance were never introduced to each other. We will show you what the joined view looks like, on screen, in thirty minutes.